# Navelbine, Taxol, Herceptin and Neupogen in Stage IV Breast Cancer: A Phase I - II Trial

> **NCT00041470** · PHASE1,PHASE2 · TERMINATED · sponsor: **University of Washington** · enrollment: 38 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** Paclitaxel
- **DRUG:** Vinorelbine
- **DRUG:** Herceptin
- **DRUG:** Filgrastim

## Key facts

- **NCT ID:** NCT00041470
- **Lead sponsor:** University of Washington
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2001-03
- **Primary completion:** 2008-08
- **Final completion:** 2008-08
- **Target enrollment:** 38 (ACTUAL)
- **Why stopped:** Sponsor withdrew the study
- **Last updated:** 2017-07-17

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00041470

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00041470, "Navelbine, Taxol, Herceptin and Neupogen in Stage IV Breast Cancer: A Phase I - II Trial". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00041470. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*